Back
Corporate News
Fischer Medical Ventures appoints David Yeow as independent director for a five-year term
03-Sep-2026, 03:20
Fischer Medical Ventures Limited, formerly Fischer Chemic Limited, announced the appointment of David Yeow as an additional independent director with effect from September 3, 2026, for a term of five years, subject to shareholder approval. The company also reconstituted its audit committee following Yeow’s appointment, and will hold its 33rd Annual General Meeting on September 29, 2026, via video conferencing, while the company’s share transfer books will be closed from September 23, 2026, to September 29, 2026.